By contrast, HLRCC is driven by biallelic inactivation of FH, leading to fumarate accumulation, pseudohypoxia, and a highly aggressive type 2 papillary RCC phenotype [39,40]. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.